A simplified panel (AOX1, GSTP1, HAPLN3, and SLC18A2) also moderately predicted metastatic progression (qMSP; PCa n =67, mPCa n =66, controls n = 40) [121]. This evidence concerns the gene SLC18A2 and posterior cortical atrophy.